Matthias Aizenberg

The humble chest X-ray, a diagnostic workhorse for over a century, is undergoing a remarkable transformation, revealing hidden health insights that extend far beyond the thoracic cavity. A groundbreaking study demonstrates how artificial intelligence can empower this ubiquitous and low-cost imaging

In the relentless battle against neurodegenerative diseases, a new and unexpected ally has emerged from a corner of medicine previously focused on cancer treatment and immune system support. A comprehensive new study has revealed that an FDA-approved drug, used safely for over three decades,

The pervasive challenge of managing Chronic Obstructive Pulmonary Disease (COPD) has long prompted a search for more sustainable and patient-centric healthcare models that can extend beyond the confines of a clinical setting. As a leading cause of morbidity and mortality worldwide, COPD requires

For decades, clinicians have relied on a simple ratio of height to weight to gauge pregnancy risk, but a growing body of evidence suggests this cornerstone of prenatal assessment is profoundly inadequate. The use of predictive metabolomics represents a significant advancement in prenatal care and

A landmark $2.6 million investment from the Breast Cancer Research Foundation is set to catalyze a new era of scientific breakthroughs, empowering seven leading researchers at the prestigious Cancer Consortium to pursue some of the most complex and urgent questions in oncology. This strategic

Long before a name is forgotten or a memory fades, a silent war is waged within the brain, and a new pharmaceutical weapon may have just arrived to fight it on its own terms. This battleground, previously invisible, is now the focus of groundbreaking research from Northwestern University, where

A comprehensive analysis of a recent study has unveiled the pivotal role of a partner protein in supporting a key appetite-regulating protein, providing profound new insights into the molecular mechanisms governing human energy balance. This discovery, led by an international research team from the

By 2030, the tissue-engineering market is projected to exceed $32.45 billion , reflecting a profound shift in how biopharma is redefining the future of medicine. Once limited to academic labs, it has become a powerful engine of innovation in biopharma, transforming how businesses develop drugs,

Today we are joined by Ivan Kairatov, a biopharma expert with deep insights into the intersection of technology and medical innovation. For decades, the goal of HIV treatment has been management—using antiretroviral therapy to suppress the virus to undetectable levels. A true cure has remained

A groundbreaking analysis by Australian scientists has finally begun to unravel the complex biological puzzle of long COVID, identifying the key genetic and molecular drivers that cause debilitating symptoms to persist long after the initial infection has cleared. This pivotal research provides a